Tear Film Break-up Time After Instillation of Artificial Tears
NCT00681265 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2012-10-26
Summary
This study is an exploratory trial evaluating the tear film break-up time after a single eye drop instillation of over-the-counter artificial tears. The primary hypothesis is that tear film break up time will be greater for test than control eye.
Conditions
- Keratoconjunctivitis Sicca
Interventions
- DRUG
-
glycerin
Eye drop with active agent glycerin 1%, new topical ophthalmic formulation with polylysine-graft-polyethylene glycol as an excipient, single instillation.
- DRUG
-
polyethylene glycol 400/propylene glycol
Eye drop with the active agents polyethylene glycol 400 0.4% /propylene glycol 0.3%, topical ophthalmic formulation, single instillation
Sponsors & Collaborators
-
Calm Water Therapeutics LLC
lead INDUSTRY
Principal Investigators
-
James V. Aquavella, MD · University of Rochester Eye Institute
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2008-06-30
- Primary Completion
- 2008-08-31
- Completion
- 2008-08-31
Countries
- United States
Study Locations
More Related Trials
-
Artificial Tears, Tear Lipids and Tear Film Dynamics
NCT05705518 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms
NCT00938704 ·Status: COMPLETED ·Phase: PHASE4
-
Tear Osmolarity Over Time With Artificial Tears
NCT01227226 ·Status: UNKNOWN ·Phase: PHASE4
-
Tear Osmolarity Changes After Instilling Isotonic Hyaluronate Artificial Tears
NCT01614847 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects
NCT01010282 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of a New Artificial Tear Formulation Compared With Systane Ultra Multidose in Participants With Dry Eye Disease
NCT04393441 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Pharmacological Study of AL-43546 Ophthalmic Product in Subjects With Shortened Tear Film Break Up Time
NCT00760045 ·Status: COMPLETED ·Phase: PHASE2
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Pilot Study on the Use of Artificial Tears to Treat Dry Eye in Glaucoma Patients
NCT01682460 ·Status: COMPLETED ·Phase: PHASE4
-
Local Tolerability and Safety of Povidone K25 Eye Drops (Artificial Tears Containing Povidone) Versus Placebo in Healthy Volunteers
NCT00135824 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of 0.38% and 0.18% Sodium Hyaluronate Ocular Lubricants for Dry Eye in Adult Gazan Participants
NCT06851364 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Artificial Tears on Ocular Biometry Parameters
NCT06656403 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Effect of Controlled Adverse Environment (CAE) on Tear Film Stability
NCT01547936 ·Status: COMPLETED
-
Once-daily Fluorometholone vs Twice-daily Cyclosporine in Dry Eye Disease
NCT06876116 ·Status: COMPLETED ·Phase: PHASE4
-
Bilateral, Masked Comparison of PEG-400 Based Artificial Tear vs. Systane for Dry Eye Signs, Symptoms & Refractive Regression Associated With Myopic Laser in Situ Keratomilieusis (LASIK).
NCT00620893 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of the Chronic Application of Tear Formulations
NCT01384851 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of SYSTANE® BALANCE in Dry Eye Subjects With Lipid Deficiency
NCT01688726 ·Status: COMPLETED ·Phase: NA
-
Effects of NOV03 on the Tear Film
NCT05723770 ·Status: COMPLETED ·Phase: PHASE4
-
Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and Symptoms
NCT01382810 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy and Acceptability of Two Lubricant Eye Drops
NCT00756678 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Safety and Tolerability of Ocular Lubricants
NCT06571656 ·Status: TERMINATED ·Phase: NA
-
Tear Film Break-Up Time Evaluation of FID 114657
NCT01023464 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Effect of 0.003% AR-15512 on Subjects With Dry Eye Disease
NCT06544694 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study Aimed At Evaluating the Safety and Efficacy of Tear Substitute Formulations in the Treatment of Dry Eye Disease.
NCT06633471 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1
-
Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms
NCT00565669 ·Status: COMPLETED ·Phase: NA